REFERENCES
- Abbott . ( 2005 ). XINLAY, NDA 21-491. Treatment of Patients with Hormone-Refractory Prostate Cancer Metastatic to Bone, Oncologic Drugs Advisory Committee Briefing Document, http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4174B1_01_01-Abbott-Xinlay.pdf
- Abrams , D. L. , Goldman , A. L. , Launer , C. , Korvick , J. A. , Neaton , J. D. , Crane , L. R. , Grodesky , M. , Wakefield , S. , Muth , K. , Kornegay , S. , Cohn , D. , Harris , A. , Luskin-Hawk , R. , Markowitz , N. , Sampson , J. H. , Thompson , M. , and Deyton , L. (1994). A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection, New England Journal of Medicine 330: 657–552.
- Armitage , P. , McPherson , C. K. , and Rowe , B. C. ( 1969 ). Repeated Significance Tests on Accumulating Data , Journal of Royal Statistical Society, Series A, General 132 : 235 – 244 .
- Brummel , S. S. ( 2010 ). On Monitoring Group Sequential Trials in the Presence of Non-linear Information Growth and Surrogate Information, Ph.D. diss., University of California Irvine.
- Burington , B. E. and Emerson , S. S. ( 2003 ). Flexible Implementations of Group Sequential Stopping Rules Using Constrained Boundaries , Biometrics 59 : 770 – 777 .
- Demets , D. L. and Lan , K. K. G. ( 1984 ). An Overview of Sequential Methods and their Application in Clinical Trials , Communications in Statistics, Theory and Methods 13 : 2315 – 2338 .
- Emerson , S. S. , Kittelson , J. M. , and Gillen , D. L. ( 2007 ). Frequentist Evaluation of Group Sequential Designs , Statistics in Medicine 26 : 5047 – 5080 .
- Fleming , T. R. and Harrington , D. P. ( 1991 ). Counting Processes and Survival Analysis , New York : Wiley .
- Fleming , T. R. , Neaton , J. D. , Goldman , A. L. , DeMets , D. L. , Launer , C. , Korvik , J. , and Abrams , D. L. ( 1995 ). Insights from Monitoring the CPCRA Didanosine/Zalcitabine Trial , Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 ( Suppl 2 ): S9 – 18 .
- Gillen , D. L. ( 2009 ). A Random Walk Approach for Quantifying Uncertainty in Group Sequential Survival Trials , Computational Statistics & Data Analysis 3 : 609 – 620 .
- Gillen , D. L. and Emerson , S. S. ( 2005 ). Information Growth in a Family of Weighted Logrank Statistics under Repeated Analyses , Sequential Analysis 24 : 1 – 22 .
- Gombay , E. ( 2008 ). Weighted Logrank Statistics in Sequential Tests , Sequential Analysis 27 : 97 – 104 .
- Harrington , D. P. and Fleming , T. R. ( 1982 ). A Class of Rank Test Procedures for Censored Survival Data , Biometrika 69 : 553 – 566 .
- Lan , K. K. G. and DeMets , D. L. ( 1983 ). Discrete Sequential Boundaries for Clinical Trials , Biometrika 70 : 659 – 663 .
- Lan , K. K. G. and Lachin , J. M. ( 1990 ). Implementation of Group Sequential Logrank Tests in a Maximum Duration Trial , Biometrics 46 : 759 – 770 .
- Lan , K. K. G. , Rosenberger , W. F. , and Lachin , J. M. ( 1995 ). Sequential Monitoring of Survival Data with the Wilcoxon Statistic , Biometrics 51 : 1175 – 1183 .
- Mehta , C. R. and Tsiatis , A. A. ( 2001 ). Flexible Sample Size Considerations Using Information-Based Interim Monitoring , Drug Information Journal 35 : 1095 – 1112 .
- O'Brien , P. C. and Fleming , T. R. ( 1979 ). A Multiple Testing Procedure for Clinical Trials , Biometrics 35 : 549 – 556 .
- Pampallona , S. , Tsiatis , A. A. , and Kim , K. M. ( 1995 ). Spending Functions for the Type I and Type II Error Probabilities of Group Sequential Tests, Technical Report, Harvard University, Department of Biostatistics.
- Pocock , S. J. ( 1977 ). Group Sequential Methods in the Design and Analysis of Clinical Trials , Biometrika 64 : 191 – 200 .
- Tsiatis , A. A. ( 1982 ). Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , Journal of American Statistical Association 77 : 855 – 861 .
- Recommended by Edit Gombay